United Guardian (UG) Non-Current Assets (2010 - 2026)
United Guardian's (UG) quarterly Non-Current Assets came in at $877812.0 in Q2 2026, down 5.35% year-over-year from $927424.0 in Q2 2025, and down 1.15% quarter-over-quarter from $888060.0 in Q1 2026.
Analysis
United Guardian (UG) Non-Current Assets (2010 - 2026) Analysis & Trends
United Guardian has disclosed Non-Current Assets across 17 years of filings, most recently posting $877812.0 for Q2 2026.
- In Q2 2026, Non-Current Assets fell 5.35% year-over-year to $877812.0; the TTM figure through Jun 2026 stood at $3.6 million (down 7.55% YoY), while the FY2025 annual figure was $907182.0, down 19.84% from the prior year.
- Non-Current Assets came in at $877812.0 for Q2 2026 at United Guardian, down from $888060.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $1.1 million in Q4 2024 to a low of $514162.0 in Q2 2023.
- Average Non-Current Assets over 5 years is $775556.1, with a median of $734063.0 recorded in 2023.
- Year-over-year, Non-Current Assets plunged 30.48% in 2023 and surged 73.62% in 2025.
- Over 5 years, Non-Current Assets stood at $669705.0 in 2022, then rose by 0.06% to $670125.0 in 2023, then surged by 68.89% to $1.1 million in 2024, then slipped by 19.84% to $907182.0 in 2025, then fell by 3.24% to $877812.0 in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $877812.0 in Q2 2026, $888060.0 in Q1 2026, and $907182.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.03 Bn | 625.27 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 441.99 Bn | 435.42 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 366.30 Bn | 359.16 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 266.55 Bn | 258.86 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | 159.77 Bn |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn | 113.37 Bn |
| 7 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | 294.93 Mn |
| 8 | Incyte | 25.53 Bn | 20.99 Bn | 1.57 Bn | 1.85 Bn |
| 9 | United Therapeutics | 21.51 Bn | 18.85 Bn | 683.80 Mn | 3.74 Bn |
| 10 | United Guardian | 32.46 Mn | 22.87 Mn | 1.55 Mn | 877,812.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 877,812.00 |
| Mar 31, 2026 | 888,060.00 |
| Dec 31, 2025 | 907,182.00 |
| Sep 30, 2025 | 933,452.00 |
| Jun 30, 2025 | 927,424.00 |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 769,741.00 |
| Jun 30, 2024 | 692,170.00 |
| Mar 31, 2024 | 617,440.00 |
| Dec 31, 2023 | 670,125.00 |
| Sep 30, 2023 | 557,142.00 |
| Jun 30, 2023 | 514,162.00 |
| Mar 31, 2023 | 698,385.00 |
| Dec 31, 2022 | 669,705.00 |
| Sep 30, 2022 | 801,364.00 |
| Jun 30, 2022 | 602,644.00 |
| Mar 31, 2022 | 629,446.00 |
| Dec 31, 2021 | 658,862.00 |
| Sep 30, 2021 | 663,533.00 |